Zhejiang Ausun Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 764.23 million compared to CNY 568.89 million a year ago. Revenue was CNY 764.55 million compared to CNY 569.7 million a year ago.

Net income was CNY 235.38 million compared to CNY 145.93 million a year ago. Basic earnings per share from continuing operations was CNY 0.4214 compared to CNY 0.2571 a year ago. Diluted earnings per share from continuing operations was CNY 0.4214 compared to CNY 0.2571 a year ago.